欢迎光临源叶生物,登录 | 注册 |
当前位置: 首页 > 小分子化合物 > 小分子抑制剂 > RVX 208

商品分类

浏览历史

S80050

RVX 208

MedMol 99%
  • 英文名:
  • Apabetalone
  • 别名:
  • 2-[3,5-二甲基-4-(2-羟基乙氧基)苯基]-5,7-二甲氧基喹唑啉-4(3H)-酮
  • CAS号:
  • 1044870-39-4
  • 分子式:
  • C20H22N2O5
  • 分子量:
  • 370.4
  • 核磁/质谱:
品牌货号产品规格价格(RMB)库存(上海) 北京 武汉 南京 数量计量单位 加入购物车...
MedMol S80050-2mg 99% ¥100.00元 4 0 0 0 EA 加入购物车
MedMol S80050-5mg 99% ¥144.00元 9 0 0 0 EA 加入购物车
MedMol S80050-10mg 99% ¥204.00元 8 0 0 0 EA 加入购物车
MedMol S80050-25mg 99% ¥370.00元 8 0 0 0 EA 加入购物车
MedMol S80050-50mg 99% ¥510.00元 预计交期:2-3天 0 0 0 EA 加入购物车
MedMol S80050-100mg 99% ¥760.00元 4 0 0 0 EA 加入购物车
大包装询价

提交您的电话号码并同意《个人信息授权与保护申明》,到货后将短信提示。
提交

产品介绍

参考文献

质检证书(COA)

摩尔浓度计算器

相关产品

  • 提示:详情请下载说明书。
  • 产品描述: Apabetalone (RVX-208) is an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. The IC50s are 87 μM and 0.51 μM for BD1 and BD2, respectively
  • 靶点: IC50: 510±41 nM (BD2), 87±10 μM (BD1)
  • 体内研究: In the atherosclerosis prophylactic treatment study design, mice are fed a Western diet concurrent with the treatment with 150 mg/kg/dose b.i.d. for 12 weeks. Mice are sacrificed at 12 weeks after treatment. There is a progressive increase in body weight in both the vehicle treated as well as the Apabetalone (RVX-208) treated groups. However, there is only an increase of 4 g (from 24 g to 28 g) body weight after 12 weeks on Western diet in the Apabetalone treated group whereas this increase is found to be 9 g (25 g-34 g) in the vehicle treated group. The significant decrease in body weight gain in Apabetalone treated mice is not due to decreased feed consumption, suggesting a positive attribute of the molecule. Plasma lipid measurements are done at 6 weeks and 12 weeks of treatment with either the vehicle or Apabetalone. Compared to the vehicle control animals, Apabetalone treated mice show significant increase (~200%) in the levels of HDL-C at 6 weeks of treatment, which is sustained until end of the study (12 weeks)
  • 参考文献:
    1. Picaud S, et al. RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc Natl Acad Sci U S A. 2013 Dec 3;110(49):19754-9. 2. McLure KG, et al. RVX-208, an inducer of ApoA-I in humans, is a BET bromodomain antagonist. PLoS One. 2013 Dec 31;8(12):e83190. 3. Jahagirdar R, et al. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice. Atherosclerosis. 2014 Sep;236(1):91-100.
  • 溶解性: DMSO  :  ≥  33  mg/mL  (89.09  mM)
  • 保存条件: -20℃
  • 配置溶液浓度参考:
    1mg 5mg 10mg
    1 mM 2.7 ml 13.499 ml 26.998 ml
    5 mM 0.54 ml 2.7 ml 5.4 ml
    10 mM 0.27 ml 1.35 ml 2.7 ml
    50 mM 0.054 ml 0.27 ml 0.54 ml
  • 注意:部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。
输入产品批号:

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:


质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子量 (g/mol)


  • =
    *
    *


源叶所有产品仅用作科学研究,销售产品行为均适用于我司网上所列通用销售条款。